Overview
Download factsheetA fully invested equity strategy that aims to provide investors with growing levels of income with resilient capital growth by investing at least 80% of its assets in UK and overseas equities.
What does the fund do?
We manage a concentrated portfolio of 30-50 high-quality, cash-generative companies that are capable of consistent dividend growth. At least 60% of the Fund is invested in UK equities with a maximum if 30% invested in overseas equities.
Our long-term approach and focus on reasonably valued, high-quality, sustainable and cash generative companies leads to low portfolio turnover. The fund will invest in accordance with the parameters of its ethical exclusion criteria, which consider ethical issues in relation to: fossil fuels, pornography, tobacco and certain types of armaments.
View our ethical exclusion criteria
Why this fund?
We believe our approach to income investing is differentiated through; our conservative quality-orientated process, our focus on total return and our prioritisation of dividend growth above high yield.
We seek a sensible balance between capital and income return in order to deliver above average returns with below average volatility.
The strategy has no explicit yield target and instead we emphasise real growth and long-term sustainability of the income stream above producing the highest dividend yield today. In so doing, we aim to deliver investors a growing yield on their initial investment.
In addition to the Ethical Exclusion Criteria the The Fund integrates ESG and stewardship in accordance with Troy’s Responsible Investment & Stewardship Policy and also adheres to Troy’s Climate Change Mitigation Policy, in accordance with article 8 of SFDR.
View our SFDR disclosure
Key facts
‘O’ ACC SHARE CLASS as at 08/12/2023
141.94p
Fund size as at 31/10/2023
£215m
‘O’ INC SHARE CLASS as at 08/12/2023
115.79p
Performance
Source: Lipper, Link Fund Solutions Limited
06/01/2016 | 30/11/2018 | 30/11/2020 | 30/11/2022 | 31/05/2023 | |
---|---|---|---|---|---|
Since Launch | 5 Years | 3 Years | 1 Year | 6 Months | |
FTSE All-Share TR | 61.6 | 26.8 | 27.3 | 1.8 | 1.6 |
Trojan Ethical Income O Acc | 39.3 | 14.6 | 4.7 | 3.2 | 0.1 |
Discrete Calendar Annual Returns (%) | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Trojan Ethical Income O Acc | 8 | 10.2 | -2.9 | 23.9 | -6 | 12.1 | -11.2 | 3.9 |
Performance is calculated on a total return basis, net of fees, in sterling terms. Past performance is not a guide to future performance
Source: Lipper, Link Fund Solutions Limited. Since Launch (06/01/2016) to 30 November 2023.
Risk and Volatility since launch
Source: Lipper, Link Fund Solutions Limited
Risk Analysis Since Launch (06/01/2016) | Trojan Ethical Income O Acc | FTSE All-Share TR |
---|---|---|
Total Return | 39.3 | 61.6 |
Max Drawdown | -25.4 | -35.3 |
Best Month | 6.6 | 12.7 |
Worst Month | -9.1 | -15.1 |
Positive Months | 61.7 | 61.7 |
Annualised Volatility | 10.2 | 12.6 |
Performance is calculated on a total return basis, net of fees, in sterling terms.
Maximum Drawdown measures the worst investment period
Annualised Volatility is measured by the annualised standard deviation of the monthly returns
Source: Lipper, Link Fund Solutions Limited. As at 30 November 2023.
Asset allocation
Top 10 holdings | Fund % |
---|---|
RELX | 6.7823593743611 |
Unilever | 6.33096953205688 |
Reckitt Benckiser | 5.37128900231222 |
Experian | 4.05409988988329 |
Compass | 3.80486452732997 |
Bunzl | 3.75673178723429 |
Nestle | 3.38470275084889 |
GSK | 3.35835301279774 |
National Grid | 3.07468632308009 |
Novartis | 2.93457653559737 |
Total Top 10 | 42.8526327355019 |
31 Other Equity holdings | 52.6013144630199 |
Cash | 4.54605280147824 |
Total | 100 |
Asset allocation and holdings subject to change. As at 30 November 2023.
Fund literature
Document name | Date | Open/download | Archived documents |
---|---|---|---|
Factsheet | View archive | ||
UCITS KIID | View share classes | ||
Fund Information Sheet |
View document Download document | ||
Prospectus & Additional Investor Information | View documents | ||
Sustainability-related Disclosures |
View document Download document | ||
Troy’s Ethical Exclusion Criteria |
View document Download document | ||
Newsletters | View newsletters | ||
Annual Report |
January 2023 | View document Download document | |
Interim Report |
July 2023 | View document Download document |
-
Factsheet
View archive OpenDownload
-
UCITS KIID
View share classes Download -
Fund Information Sheet
Open Download -
Prospectus & Additional Investor Information
View documents OpenDownload
-
Sustainability-related Disclosures
Open Download -
Troy’s Ethical Exclusion Criteria
Open Download -
Newsletters
View newsletters OpenDownload
-
Annual Report
Date: January 2023 Open Download -
Interim Report
Date: July 2023 Open Download
Past performance is not a guide to future performance. The value of a fund and any income from it may go down as well as up and investors may get back less than they invested. Changes in rates of exchange may cause the value of investments to go up or down. Returns may increase or decrease as a result of currency fluctuations. This data is provided for information only and should not be reproduced, published or disseminated in any manner. Although Troy considers the data to be reliable, no warranty is given as to its accuracy or completeness. Any comparisons against indices are for illustrative purposes only. In line with the Fund’s prospectus, the Fund is authorised to invest in transferable securities and money market instruments issued or guaranteed by an EEA state, one or more local authorities, a third country, or a public international body to which one or more EEA states belong. The Investment Manager would only consider investing more than 35% of the Fund’s assets in UK or US government issued transferable securities or approved money market instruments.
Some of the information contained on this page: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Important information for U.S. persons
The securities described on this website are neither available nor offered in the United States of America (including the District of Columbia or any other territory occupied or possessed by the United States of America) or to U.S. persons (including residents of the United States of America, residents within an area subject to its jurisdiction and U.S. persons who are resident outside the United States of America).
For the full fund disclaimer please refer to the Fund factsheet.
How to invest
Find more information on how to invest in this fund and where it is available.
How to invest
Commentary
October 2023
Your Fund delivered a total return of -3.5% during the month, compared with -4.1% from the FTSE All-Share Index (TR).
The tragic developments in Israel and Palestine hurt market sentiment as it renewed investors’ focus on the elevated macroeconomic and geopolitical risks. All sectors excluding Utilities delivered negative returns for the UK index. Financials was the worst performing sector following results from most of the large banks including Lloyds and Barclays, causing their share prices to fall more than 10% in the month. Your Fund has no exposure to banks which meant that while it was not immune, it reassuringly outperformed the All-Share Index in a weak market.
The Fund’s top contributors in the month of October were RELX (+3.5%) and CME (+7.3%). RELX reported a strong Q3 trading update, reiterating its ambitions to grow revenue and profit above historical trends. CME, which is one of your Fund’s overseas holdings, also provided a good update on performance. The company has a monopoly over the trading of US interest rate derivatives which play a key role in helping hedge interest rate risks. As we move from a decade of artificially low rates to a more normalized environment, demand for its products will structurally support revenue growth. Other notable performers were Compass Group (3.7%) and Procter & Gamble (+4.1%).
The biggest detractors for the month were St James’s Place (-23.1%), Reckitt Benckiser (-5.4%) and Unilever (-4.3%), Experian (-7.4%), and Croda (-10.9%). The Consumer Staples sector was weak despite reporting results that were in line with market expectations. St James’s Place and Croda both warned that profits would be lower than expected. For St James’s Place, this was because of a change in fee structure in response to the FCA’s Consumer Duty. Whilst disruptive in the short term, we view this as a significant move in making the client proposition more competitive going forward. Croda saw sequential improvements in trading, however the pace of recovery was slower than expected. These are all high-quality businesses with compelling valuations. They remain core holdings in the Fund.